Neurotrauma is the largest cause of death and disability for persons under the age of 45 in the world and the
societal cost of the resulting disability exceeds $76 billion per year in the United States. The annual meeting of
the National Neurotrauma Society (NNS) is the premier forum for exchanging information on the latest research
findings and clinical advances in the fields of both traumatic brain injury (TBI) and spinal cord injury (SCI). The
38th Annual Neurotrauma Symposium will held June 27-July 1, 2020, at the Peachtree Westin in downtown
Atlanta, GA. Previous NIH funding has been invaluable for supporting our scientific programs and for enhancing
our ability to involve trainees and underrepresented groups (URG) and to enhance their careers. The symposium
is again co-hosted by the NNS and the AANS/CNS Joint Section on Neurotrauma and Critical Care (AANAS/CNS
JSNCC). The Scientific Program Committee is comprised of members of both societies to ensure that there is
a breadth of coverage for both TBI and SCI across basic and clinical investigations, as well as committee
representation of URG. Building upon decades of basic and clinical research, the meeting theme this year will
be “Bidirectional Translation” to highlight not only the latest advances in the preclinical space and how these
advances inform strategies for improving clinical outcome following neurotrauma, but also how real-world patient
information can guide preclinical research. We have tried to incorporate speakers and topics that have not
previously been emphasized in prior meetings and who represent URG. Topics include updates on cellular
therapy for SCI, repetitive blast exposure, data sharing, opioid use following neurotrauma, and novel biomarkers,
among others. In addition to dissemination of the most recent scientific and clinical findings, we will also highlight
the population and policy ends of the translational pipeline. Taking advantage of being in Atlanta for the first
time, the program will include the epidemiology of neurotrauma from the Centers for Disease Control. In addition,
we will include advocacy as a plenary session, an idea developed from a very well received lunch workshop at
the 2019 meeting. As in recent years, patient perspectives will provide personal viewpoints on living with brain
and spinal cord injury, and their views regarding scientific priorities and advocacy. This application seeks funding
to provide travel support for 25 trainees (including 5 full conference support awards to URMs or attendees with
disabilities) to attend the Symposium, for child care assistance, and to support sessions dedicated to trainee
development and to increases diversity and inclusion within the society and symposium. There will be three
special lunch workshops hosted by our TEAM (Training, Education, and Mentoring) group on trainee fellowships,
the NIH review process, and increasing diversity and inclusion in the trainee pipeline. This year we will focus on
increasing diversity among our trainees and faculty, as we recognize that the future success of the society and
the field of neurotrauma will be strengthened by intentionally recognizing the need for inclusion and developing
awareness and programming around diversity and inclusion.